147 related articles for article (PubMed ID: 38523651)
1. Evaluation of Features in Probably Benign and Malignant Nonmass Enhancement in Breast MRI.
Ahmadinejad N; Azizinik F; Khosravi P; Torabi A; Mohajeri A; Arian A
Int J Breast Cancer; 2024; 2024():6661849. PubMed ID: 38523651
[TBL] [Abstract][Full Text] [Related]
2. The MRI characteristics of non-mass enhancement lesions of the breast: associations with malignancy.
Aydin H
Br J Radiol; 2019 Apr; 92(1096):20180464. PubMed ID: 30673299
[TBL] [Abstract][Full Text] [Related]
3. Significance of Additional Non-Mass Enhancement in Patients with Breast Cancer on Preoperative 3T Dynamic Contrast Enhanced MRI of the Breast.
Cho YH; Cho KR; Park EK; Seo BK; Woo OH; Cho SB; Bae JW
Iran J Radiol; 2016 Jan; 13(1):e30909. PubMed ID: 27127579
[TBL] [Abstract][Full Text] [Related]
4. Non-mass enhancement breast lesions: MRI findings and associations with malignancy.
Liu G; Li Y; Chen SL; Chen Q
Ann Transl Med; 2022 Mar; 10(6):357. PubMed ID: 35433999
[TBL] [Abstract][Full Text] [Related]
5. Revisiting Nonmass Enhancement in Breast MRI: Analysis of Outcomes and Follow-Up Using the Updated BI-RADS Atlas.
Chikarmane SA; Michaels AY; Giess CS
AJR Am J Roentgenol; 2017 Nov; 209(5):1178-1184. PubMed ID: 28834447
[TBL] [Abstract][Full Text] [Related]
6. Interobserver variability and likelihood of malignancy for fifth edition BI-RADS MRI descriptors in non-mass breast lesions.
Lunkiewicz M; Forte S; Freiwald B; Singer G; Leo C; Kubik-Huch RA
Eur Radiol; 2020 Jan; 30(1):77-86. PubMed ID: 31392476
[TBL] [Abstract][Full Text] [Related]
7. Discriminative Factors of Malignancy of Ipsilateral Nonmass Enhancement in Women With Newly Diagnosed Breast Cancer on Initial Staging Breast MRI.
Jirarayapong J; Chikarmane SA; Portnow LH; Farah S; Gombos EC
J Magn Reson Imaging; 2024 May; 59(5):1725-1739. PubMed ID: 37534882
[TBL] [Abstract][Full Text] [Related]
8. Apocrine Metaplasia Found at MR Biopsy: Is There Something to be Learned?
Gao Y; Dialani V; DeBenedectis C; Johnson N; Brachtel E; Slanetz P
Breast J; 2017 Jul; 23(4):429-435. PubMed ID: 28079289
[TBL] [Abstract][Full Text] [Related]
9. Histopathologic Correlates of Nonmass Enhancement Detected by Breast Magnetic Resonance Imaging.
Torous VF; Resteghini NA; Phillips J; Dialani V; Slanetz PJ; Schnitt SJ; Baker GM
Arch Pathol Lab Med; 2021 Oct; 145(10):1264-1269. PubMed ID: 33450753
[TBL] [Abstract][Full Text] [Related]
10. Limited role of DWI with apparent diffusion coefficient mapping in breast lesions presenting as non-mass enhancement on dynamic contrast-enhanced MRI.
Avendano D; Marino MA; Leithner D; Thakur S; Bernard-Davila B; Martinez DF; Helbich TH; Morris EA; Jochelson MS; Baltzer PAT; Clauser P; Kapetas P; Pinker K
Breast Cancer Res; 2019 Dec; 21(1):136. PubMed ID: 31801635
[TBL] [Abstract][Full Text] [Related]
11. Breast Nonmass Enhancement Detected with MRI: Uility and Lesion Characterization with Second-Look Ultrasonography.
Hsu HH; Chang TH; Chou YC; Peng YJ; Ko KH; Chang WC; Lin YP; Hsu GC; Yu JC
Breast J; 2015; 21(6):579-87. PubMed ID: 26390913
[TBL] [Abstract][Full Text] [Related]
12. Management of Non-Mass Enhancement at Breast Magnetic Resonance in Screening Settings Referred for Magnetic Resonance-Guided Biopsy.
de Faria Castro Fleury E; Castro C; do Amaral MSC; Roveda Junior D
Breast Cancer (Auckl); 2022; 16():11782234221095897. PubMed ID: 35602239
[TBL] [Abstract][Full Text] [Related]
13. Nonmass Enhancement Breast Lesions: Diagnostic Performance of Kinetic Assessment on Ultrafast and Standard Dynamic Contrast-Enhanced MRI in Comparison With Morphologic Evaluation.
Mori N; Sheth D; Abe H
AJR Am J Roentgenol; 2020 Aug; 215(2):511-518. PubMed ID: 32452698
[No Abstract] [Full Text] [Related]
14. Value of breast MRI for patients with a biopsy showing atypical ductal hyperplasia (ADH).
Tsuchiya K; Mori N; Schacht DV; Sheth D; Karczmar GS; Newstead GM; Abe H
J Magn Reson Imaging; 2017 Dec; 46(6):1738-1747. PubMed ID: 28295791
[TBL] [Abstract][Full Text] [Related]
15. Role of combined clinical-radiomics model based on contrast-enhanced MRI in predicting the malignancy of breast non-mass enhancements without an additional diffusion-weighted imaging sequence.
Li Y; Yang Z; Lv W; Qin Y; Tang C; Yan X; Yin T; Ai T; Xia L
Quant Imaging Med Surg; 2023 Sep; 13(9):5974-5985. PubMed ID: 37711822
[TBL] [Abstract][Full Text] [Related]
16. Radiologic-Pathologic Correlation of Nonmass Enhancement Contiguous with Malignant Index Breast Cancer Masses at Preoperative Breast MRI.
Nguyen DL; Lotfalla M; Cimino-Mathews A; Habibi M; Ambinder EB
Radiol Imaging Cancer; 2024 Mar; 6(2):e230060. PubMed ID: 38305717
[TBL] [Abstract][Full Text] [Related]
17. Clumped vs non-clumped internal enhancement patterns in linear non-mass enhancement on breast MRI.
Chen ST; Covelli J; Okamoto S; Daniel BL; DeMartini WB; Ikeda DM
Br J Radiol; 2021 Feb; 94(1118):20201166. PubMed ID: 33332980
[TBL] [Abstract][Full Text] [Related]
18. MRI-detected suspicious breast lesions: predictive values of kinetic features measured by computer-aided evaluation.
Wang LC; DeMartini WB; Partridge SC; Peacock S; Lehman CD
AJR Am J Roentgenol; 2009 Sep; 193(3):826-31. PubMed ID: 19696298
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of mammography for accompanying non-mass enhancement on preoperative breast MRI.
Kim Y; Jung HK; Park AY; Ko KH; Jang H
Acta Radiol; 2022 Aug; 63(8):1032-1042. PubMed ID: 34260322
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of MRI-Directed Breast Ultrasound and Lesion Characteristics Affecting Visualization on Breast Ultrasound.
Xiao L; Simmons C; Khanani S
Curr Probl Diagn Radiol; 2022; 51(5):717-721. PubMed ID: 35272882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
